DK41289A - Proteolytisk enzym, der er specifikt for human immundefektvirus og en fremgangsmaade til dets syntese og renaturering - Google Patents

Proteolytisk enzym, der er specifikt for human immundefektvirus og en fremgangsmaade til dets syntese og renaturering

Info

Publication number
DK41289A
DK41289A DK041289A DK41289A DK41289A DK 41289 A DK41289 A DK 41289A DK 041289 A DK041289 A DK 041289A DK 41289 A DK41289 A DK 41289A DK 41289 A DK41289 A DK 41289A
Authority
DK
Denmark
Prior art keywords
hiv
specific
synthesis
reneating
immundefect
Prior art date
Application number
DK041289A
Other languages
English (en)
Other versions
DK41289D0 (da
Inventor
Stephen Oroszlan
Terry Duane Copeland
Original Assignee
Bionetics Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionetics Research Inc filed Critical Bionetics Research Inc
Publication of DK41289D0 publication Critical patent/DK41289D0/da
Publication of DK41289A publication Critical patent/DK41289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK041289A 1987-06-01 1989-01-30 Proteolytisk enzym, der er specifikt for human immundefektvirus og en fremgangsmaade til dets syntese og renaturering DK41289A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/057,183 US5252477A (en) 1987-06-01 1987-06-01 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
PCT/US1988/001849 WO1988009815A1 (en) 1987-06-01 1988-06-01 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation

Publications (2)

Publication Number Publication Date
DK41289D0 DK41289D0 (da) 1989-01-30
DK41289A true DK41289A (da) 1989-01-30

Family

ID=22009015

Family Applications (1)

Application Number Title Priority Date Filing Date
DK041289A DK41289A (da) 1987-06-01 1989-01-30 Proteolytisk enzym, der er specifikt for human immundefektvirus og en fremgangsmaade til dets syntese og renaturering

Country Status (10)

Country Link
US (2) US5252477A (da)
EP (1) EP0316429B1 (da)
JP (1) JPH02500408A (da)
KR (1) KR890701738A (da)
AT (1) ATE105859T1 (da)
AU (1) AU630590B2 (da)
DE (1) DE3889625T2 (da)
DK (1) DK41289A (da)
FI (1) FI890459A (da)
WO (1) WO1988009815A1 (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147369A (en) * 1991-07-01 1992-09-15 Wagner Michael A Forceps and method for nuclear fragment removal

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252477A (en) * 1987-06-01 1993-10-12 The United States Of America As Represented By The United States Department Of Health And Human Services Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
US5637488A (en) * 1987-06-01 1997-06-10 The United States Of America As Represented By The Department Of Health And Human Services HIV protease gene and method for its expression
CA1340748C (en) * 1988-07-13 1999-09-14 Stephen Oroszlan Synthetic hiv protease gene and method for its expression
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US5679688A (en) * 1992-03-11 1997-10-21 Narhex Limited Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5872210A (en) * 1995-10-05 1999-02-16 The United States Of America As Represented By The Department Of Health And Human Services Transframe peptide inhibitor of viral protease
DE69734656T2 (de) 1996-04-30 2006-08-10 Twinstrand Therapeutics Inc., Burnaby Antivirale variante von ricin-proteinen
US6531125B1 (en) 1999-03-02 2003-03-11 Twinstrand Therapeutics Inc. Antiviral ricin-like proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252477A (en) * 1987-06-01 1993-10-12 The United States Of America As Represented By The United States Department Of Health And Human Services Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147369A (en) * 1991-07-01 1992-09-15 Wagner Michael A Forceps and method for nuclear fragment removal

Also Published As

Publication number Publication date
US5354683A (en) 1994-10-11
ATE105859T1 (de) 1994-06-15
DE3889625T2 (de) 1994-09-29
AU630590B2 (en) 1992-11-05
JPH02500408A (ja) 1990-02-15
FI890459A0 (fi) 1989-01-31
DK41289D0 (da) 1989-01-30
DE3889625D1 (de) 1994-06-23
EP0316429A1 (en) 1989-05-24
AU1805188A (en) 1989-01-04
EP0316429A4 (en) 1991-05-22
KR890701738A (ko) 1989-12-21
US5252477A (en) 1993-10-12
FI890459A (fi) 1989-01-31
WO1988009815A1 (en) 1988-12-15
EP0316429B1 (en) 1994-05-18

Similar Documents

Publication Publication Date Title
DK41289D0 (da) Proteolytisk enzym, der er specifikt for human immundefektvirus og en fremgangsmaade til dets syntese og renaturering
DE68912359D1 (de) Proteolytische Enzyme und ihre Verwendung in Waschmitteln.
ATE26914T1 (de) Gebogene heftklammer.
ATE80657T1 (de) Mischungen von alpha-amylase zur verfluessigung von staerke.
ATE130031T1 (de) Verwendungen viraler enzyme.
DE3878991D1 (de) Peptide boronsaeure-hemmungsstoffe von trypsintyp-proteasen.
AU638133B2 (en) Ribosome inactivating proteins, inactive precursor forms thereof, a process for making and a method of using
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
DK0909312T3 (da) Fremgangsmåde til fremstilling af polypeptider
IT1050910B (it) Enzima proteolitico particolarmente per composizioni biodetergenti..e procedimento per la sua preparazione
DE3788216D1 (de) Gentechnologisch hergestellter pankreatischer sekretorischer Trypsininhibitor und seine Varianten.
ES8601236A1 (es) Un procedimiento para la preparacion de derivados peptidicos
ATE5314T1 (de) Pharmakologisch aktive peptide und deren zusammensetzungen.
DK316984A (da) Fremgangsmaade til oploesning af peptider
ES2078072T3 (es) Inmunogeno y su utilizacion para la obtencion de anticuerpos contra hba1c.
IT8321281A0 (it) Un vetro-inverso analogo del decapeptide (5-14)dell'angiotensinogeno equino inibitore specifico della renina con elevata resistenza all'idrolisi enzimatica.
ATE109796T1 (de) Gewebeinhibitor für metalloproteasen (timp-2).
ATE125547T1 (de) Hiv protease-hemmer.
EP0236040A3 (en) Amino acid modified prourokinase and method of preparation
HUP0001284A2 (hu) Humán prohormon konvertáz 4
NO894362D0 (no) Fremgangsmaate for selektiv spaltning av fusjonsproteiner.
NO890402L (no) Human-immundefisient virus-spesifikt proteolytisk enzym og fremgangsmaate for dets syntese og renaturering.
NO944411L (no) Endoprotease med en ny spaltningsspesifisitet
RO96183B1 (ro) Procedeu pentru hidrogenarea selectiva a ciclopentadienei la ciclopentena
ES2009280A6 (es) Un metodo para detectar anticuerpos al virus hiv-1 en una muestra.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment